Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
51 studies found for:    "epidermolysis bullosa simplex" OR "Epidermolysis Bullosa"
Show Display Options
RSS Create an RSS feed from your search for:
"epidermolysis bullosa simplex" OR "Epidermolysis Bullosa"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Study of Inflammatory Mechanisms in Epidermolysis Bullosa Simplex- Dowling Meara
Condition: Epidermolysis Bullosa Simplex Dowling Meara
Intervention: Procedure: Taking of liquid and top of blisters
2 Not yet recruiting Diacerin for the Treatment of Epidermolysis Bullosa Simplex
Condition: Epidermolysis Bullosa Simplex
Intervention: Drug: Diacerin cream
3 Unknown  Botulinumtoxin A Treatment in Epidermolysis Bullosa Simplex and Pachyonychia Congenita
Condition: Epidermolysis Bullosa Simplex
Interventions: Drug: Dysport® (Botulinumtoxin A (Btx A));   Drug: Placebo
4 Unknown  Treatment of Dowling Maera Type of Epidermolysis Bullosa Simplex by Oral Erythromycin
Condition: Epidermolysis Bullosa
Intervention: Drug: Oral erythromycin
5 Recruiting Effect of Broccoli Sprout Extract on Keratinocyte Differentiation in Normal Skin
Conditions: Epidermolysis Bullosa Simplex;   Pachyonychia Congenita
Interventions: Drug: Jojoba oil with broccoli sprout extract;   Drug: Jojoba oil (placebo)
6 Recruiting Gene Transfer for Recessive Dystrophic Epidermolysis Bullosa
Conditions: Epidermolysis Bullosa Dystrophica;   Epidermolysis Bullosa
Intervention: Genetic: LZRSE-Col7A1 Engineered Autologous Epidermal Sheets (LEAES)
7 Terminated
Has Results
Safety and Efficacy of Apligraf in Nonhealing Wounds of Subjects With Junctional or Dystrophic Epidermolysis Bullosa (EB)
Conditions: Epidermolysis Bullosa, Junctional;   Epidermolysis Bullosa Dystrophica
Interventions: Device: Apligraf;   Other: Standard dressing regimen
8 Completed
Has Results
Treatment of Chronic and Non-Chronic Wounds in Patients With Recessive Dystrophic Epidermolysis Bullosa Using Helicoll Collagen Dressings Versus Standard of Care
Conditions: Epidermolysis Bullosa Dystrophica;   Epidermolysis Bullosa
Interventions: Device: Helicoll;   Device: Standard of Care Dressings
9 Withdrawn Prospective, Longitudinal Natural History Study in Dystrophic Epidermolysis Bullosa
Condition: Dystrophic Epidermolysis Bullosa
Intervention:
10 Unknown  Allogeneic Stem Cell Transplantation (ALLOSCT) in Recessive Dystrophic Epidermolysis Bullosa (RDEB)
Condition: Epidermolysis Bullosa
Intervention: Drug: Reduced Intensity Transplant conditioning
11 Recruiting Study to Evaluate the Safety of ALLO-ASC-DFU in the Subjects With Dystrophic Epidermolysis Bullosa
Condition: Dystrophic Epidermolysis Bullosa
Intervention: Other: Allogeneic mesenchymal stem cells
12 Withdrawn A Pilot Study of HP802-247 in Dystrophic Epidermolysis Bullosa
Condition: Dystrophic Epidermolysis Bullosa
Interventions: Biological: HP802-247;   Other: Placebo
13 Terminated
Has Results
Allogeneic Hematopoietic Stem Cell Transplant For Epidermolysis Bullosa
Condition: Epidermolysis Bullosa
Interventions: Drug: busulfan;   Drug: cyclophosphamide;   Drug: fludarabine phosphate;   Procedure: hematopoietic bone marrow transplantation
14 Completed
Has Results
Study of Alwextin® Cream in Treating Epidermolysis Bullosa
Condition: Epidermolysis Bullosa
Intervention: Drug: Alwextin cream
15 Active, not recruiting Open Label Extension Study to Evaluate the Safety of SD-101 Cream in Subjects With Epidermolysis Bullosa
Condition: Epidermolysis Bullosa
Intervention: Drug: SD-101 dermal cream (6%)
16 Completed The Efficacy of Trimethoprim in Wound Healing of Patients With Epidermolysis Bullosa
Condition: Epidermolysis Bullosa
Intervention: Drug: Trimethoprim
17 Completed Study of Effectiveness and Safety of SD-101 in Subjects With Epidermolysis Bullosa
Condition: Epidermolysis Bullosa
Interventions: Drug: 3% SD-101 dermal cream;   Drug: 6% SD-101 dermal cream;   Drug: Vehicle (0% SD-101)
18 Recruiting ESSENCE Study: Efficacy and Safety of SD-101 Cream in Patients With Epidermolysis Bullosa
Condition: Epidermolysis Bullosa
Interventions: Drug: SD-101-6.0 cream;   Drug: SD-101-0.0 cream
19 Terminated
Has Results
A Phase 2 Study on Effect of Thymosin Beta 4 on Wound Healing in Patients With Epidermolysis Bullosa
Condition: Epidermolysis Bullosa
Interventions: Drug: Thymosin Beta 4;   Drug: Placebo
20 Active, not recruiting Open Label Extension Study to Evaluate the Long-term Safety of Zorblisa (SD-101-6.0) in Patients With Epidermolysis Bullosa
Condition: Epidermolysis Bullosa
Intervention: Drug: Zorblisa (SD-101-6.0) cream

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years